8-38290632-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_023034.2(NSD3):c.2961C>T(p.Asn987=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000614 in 1,613,962 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00098 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00058 ( 7 hom. )
Consequence
NSD3
NM_023034.2 synonymous
NM_023034.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
NSD3 (HGNC:12767): (nuclear receptor binding SET domain protein 3) This gene is related to the Wolf-Hirschhorn syndrome candidate-1 gene and encodes a protein with PWWP (proline-tryptophan-tryptophan-proline) domains. This protein methylates histone H3 at lysine residues 4 and 27, which represses gene transcription. Two alternatively spliced variants have been described. [provided by RefSeq, May 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 8-38290632-G-A is Benign according to our data. Variant chr8-38290632-G-A is described in ClinVar as [Benign]. Clinvar id is 713975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 149 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NSD3 | NM_023034.2 | c.2961C>T | p.Asn987= | synonymous_variant | 17/24 | ENST00000317025.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NSD3 | ENST00000317025.13 | c.2961C>T | p.Asn987= | synonymous_variant | 17/24 | 1 | NM_023034.2 | P4 | |
NSD3 | ENST00000527502.5 | c.2961C>T | p.Asn987= | synonymous_variant | 17/24 | 1 | |||
NSD3 | ENST00000433384.6 | c.2814C>T | p.Asn938= | synonymous_variant | 16/23 | 1 | A1 | ||
NSD3 | ENST00000526050.1 | n.117C>T | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000973 AC: 148AN: 152180Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
148
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00240 AC: 599AN: 249270Hom.: 7 AF XY: 0.00183 AC XY: 247AN XY: 135236
GnomAD3 exomes
AF:
AC:
599
AN:
249270
Hom.:
AF XY:
AC XY:
247
AN XY:
135236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000576 AC: 842AN: 1461664Hom.: 7 Cov.: 31 AF XY: 0.000509 AC XY: 370AN XY: 727142
GnomAD4 exome
AF:
AC:
842
AN:
1461664
Hom.:
Cov.:
31
AF XY:
AC XY:
370
AN XY:
727142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000978 AC: 149AN: 152298Hom.: 2 Cov.: 32 AF XY: 0.000860 AC XY: 64AN XY: 74456
GnomAD4 genome
AF:
AC:
149
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
64
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 22, 2018 | - - |
NSD3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at